--- Chain 20 for Question 88 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: A
Prompt Tokens (Usage): 168
Completion Tokens (Usage): 844
Reasoning Tokens (Counted): 581
Non-Reasoning Tokens (Counted): 261
Total Tokens (Usage): N/A

--- Reasoning Content ---
Okay, so I've got this question about rotavirus and some immune response processes. Hmm, let's break it down. 

Alright, the setup: someone tagged inner capsid proteins of rotavirus with GFP and gave it to mice orally. Then they saw some fluorescence destroyed by stomach acid and some tangled in intestinal mucus before reaching secondary lymphoid organs. They looked at the Peyer's patches and isolated the proliferating cells. The variable heavy chain genes have high variability. The question is about which process is happening.

Wait, so Peyer's patches are part of the gut-associated lymphoid tissue, right? They're specialized for sampling antigens in the intestine. So when the GFP-tagged proteins are given via oral gavage, they'd probably be taken up by these patches.

But some of the GFP was destroyed by stomach acid. Oh, right, the stomach has a lot of acid which can break down proteins. So maybe not all the proteins made it through. But some did reach the Peyer's patches. Once there, the immune cells would process them. 

In the Peyer's patches, the antigens are taken up by antigen-presenting cells like M cells or macrophages. From there, the antigens are processed and presented to T cells and B cells. When B cells are activated, they start proliferating and differentiating. 

The question says they isolated the proliferating cell population. So these must be B cells that are activated. When B cells proliferate, they undergo a process that increases the diversity of their antibodies. I remember that during this process, the B cells undergo something called somatic hypermutation. 

Wait, what's somatic hypermutation? Oh right, it's a process where mutations are introduced into the variable regions of the B cell receptor (BCR) genes during the proliferation phase. This increases the chance that the B cell will produce a more specific antibody, enhancing the immune response. This process occurs in the germinal centers of lymphoid tissues, which are sites of active B cell proliferation and differentiation.

The high variability in the variable heavy chain genes suggests that each cell has a slightly different sequence, which is exactly what happens when somatic hypermutation occurs. Each mutation leads to a different antibody variant, allowing the immune system to respond more effectively to the antigen.

The other options: complement activation (B) is about the complement system lysis of pathogens, doesn't directly explain the gene variability. Class switching recombination (C) changes the class of antibody (like from IgM to IgG), but that doesn't cause the variability in the variable regions. VDJ recombination (D) is during the initial formation of BCR in the bone marrow, leading to the initial diversity, but this is a later process in the immune response.

So the correct process is somatic hypermutation, which is option A.


--- Final Answer Content ---


The experiment involves tagging the inner capsid proteins of rotavirus with GFP and administering them to mice via oral gavage. Some fluorescence is destroyed by stomach acid, while the remaining GFP-tagged proteins reach the intestinal mucus and eventually the Peyer's patches, which are part of the gut-associated lymphoid tissue. In the Peyer's patches, the antigens are taken up by antigen-presenting cells, processed, and presented to B cells. These B cells become activated, proliferate, and differentiate, leading to the isolation of a proliferating cell population.

The sequencing of the variable heavy chain genes from these cells reveals high variability, which is characteristic of a process that introduces mutations into the variable regions of the B cell receptor (BCR) genes. This process is known as somatic hypermutation. It occurs during the proliferation phase of B cells in germinal centers, increasing the diversity of antibodies to enhance the immune response. 

The other options are not consistent with the observed phenomenon: complement activation (B) involves lysing pathogens, class switching recombination (C) changes the antibody isotype, and VDJ recombination (D) generates initial diversity during BCR development in the bone marrow. None of these processes explain the observed variability in the variable heavy chain genes.

Answer: A

--- Full Content ---
Okay, so I've got this question about rotavirus and some immune response processes. Hmm, let's break it down. 

Alright, the setup: someone tagged inner capsid proteins of rotavirus with GFP and gave it to mice orally. Then they saw some fluorescence destroyed by stomach acid and some tangled in intestinal mucus before reaching secondary lymphoid organs. They looked at the Peyer's patches and isolated the proliferating cells. The variable heavy chain genes have high variability. The question is about which process is happening.

Wait, so Peyer's patches are part of the gut-associated lymphoid tissue, right? They're specialized for sampling antigens in the intestine. So when the GFP-tagged proteins are given via oral gavage, they'd probably be taken up by these patches.

But some of the GFP was destroyed by stomach acid. Oh, right, the stomach has a lot of acid which can break down proteins. So maybe not all the proteins made it through. But some did reach the Peyer's patches. Once there, the immune cells would process them. 

In the Peyer's patches, the antigens are taken up by antigen-presenting cells like M cells or macrophages. From there, the antigens are processed and presented to T cells and B cells. When B cells are activated, they start proliferating and differentiating. 

The question says they isolated the proliferating cell population. So these must be B cells that are activated. When B cells proliferate, they undergo a process that increases the diversity of their antibodies. I remember that during this process, the B cells undergo something called somatic hypermutation. 

Wait, what's somatic hypermutation? Oh right, it's a process where mutations are introduced into the variable regions of the B cell receptor (BCR) genes during the proliferation phase. This increases the chance that the B cell will produce a more specific antibody, enhancing the immune response. This process occurs in the germinal centers of lymphoid tissues, which are sites of active B cell proliferation and differentiation.

The high variability in the variable heavy chain genes suggests that each cell has a slightly different sequence, which is exactly what happens when somatic hypermutation occurs. Each mutation leads to a different antibody variant, allowing the immune system to respond more effectively to the antigen.

The other options: complement activation (B) is about the complement system lysis of pathogens, doesn't directly explain the gene variability. Class switching recombination (C) changes the class of antibody (like from IgM to IgG), but that doesn't cause the variability in the variable regions. VDJ recombination (D) is during the initial formation of BCR in the bone marrow, leading to the initial diversity, but this is a later process in the immune response.

So the correct process is somatic hypermutation, which is option A.


The experiment involves tagging the inner capsid proteins of rotavirus with GFP and administering them to mice via oral gavage. Some fluorescence is destroyed by stomach acid, while the remaining GFP-tagged proteins reach the intestinal mucus and eventually the Peyer's patches, which are part of the gut-associated lymphoid tissue. In the Peyer's patches, the antigens are taken up by antigen-presenting cells, processed, and presented to B cells. These B cells become activated, proliferate, and differentiate, leading to the isolation of a proliferating cell population.

The sequencing of the variable heavy chain genes from these cells reveals high variability, which is characteristic of a process that introduces mutations into the variable regions of the B cell receptor (BCR) genes. This process is known as somatic hypermutation. It occurs during the proliferation phase of B cells in germinal centers, increasing the diversity of antibodies to enhance the immune response. 

The other options are not consistent with the observed phenomenon: complement activation (B) involves lysing pathogens, class switching recombination (C) changes the antibody isotype, and VDJ recombination (D) generates initial diversity during BCR development in the bone marrow. None of these processes explain the observed variability in the variable heavy chain genes.

Answer: A